OptimizeRx (OPRX) Long-Term Deferred Tax (2012 - 2024)

OptimizeRx has disclosed Long-Term Deferred Tax across 10 years of filings, most recently posting $4.5 million for Q4 2024.

• In Q4 2024, Long-Term Deferred Tax rose 3.55% year-over-year to $4.5 million; the TTM figure through Dec 2024 stood at $4.5 million (up 3.55% YoY), while the FY2024 annual figure was $4.5 million, up 3.55% from the prior year.
• Long-Term Deferred Tax came in at $4.5 million for Q4 2024 at OptimizeRx, up from $4.3 million in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $10.5 million in Q4 2022 to a low of $4.3 million in Q4 2023.
• Average Long-Term Deferred Tax over 5 years is $6.4 million, with a median of $4.5 million recorded in 2020.
• Year-over-year, Long-Term Deferred Tax surged 73.31% in 2021 and slumped 58.66% in 2023.
• Over 5 years, Long-Term Deferred Tax stood at $4.5 million in 2020, then surged by 73.31% to $7.9 million in 2021, then soared by 33.11% to $10.5 million in 2022, then tumbled by 58.66% to $4.3 million in 2023, then rose by 3.55% to $4.5 million in 2024.
• Per Business Quant data, the three most recent Long-Term Deferred Tax figures were $4.5 million in Q4 2024, $4.3 million in Q4 2023, and $10.5 million in Q4 2022.